TG Therapeutics, Inc. (TGTX)
29.80
-0.63
(-2.07%)
USD |
NASDAQ |
Dec 10, 10:07
TG Therapeutics Market Cap: 4.731B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 169.86B |
| Karyopharm Therapeutics, Inc. | 106.57M |
| Axsome Therapeutics, Inc. | 7.378B |
| Krystal Biotech, Inc. | 6.905B |
| Arcutis Biotherapeutics, Inc. | 3.639B |
Market Cap Related Metrics
| PE Ratio | 10.73 |
| PS Ratio | 9.056 |
| Price to Book Value | 7.791 |
| Price | 29.80 |
| Earnings Yield | 9.32% |
| Operating PE Ratio | 46.87 |
| Normalized PE Ratio | 10.72 |